Related Experiment Video
Updated: Aug 1, 2026
08:39
Operant Sensation Seeking in the Mouse
Published on: November 10, 2010
Enhanced morphine analgesia in mice lacking beta-arrestin 2.
L M Bohn1, R J Lefkowitz, R R Gainetdinov
1Howard Hughes Medical Institute Laboratories, Departments of Cell Biology and Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Science (New York, N.Y.)
|January 5, 2000
Summary
Beta-arrestin 2 is crucial for regulating mu opioid receptor (muOR) signaling and morphine
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- Morphine's pain relief involves the mu opioid receptor (muOR), a G protein-coupled receptor (GPCR).
- GPCR signaling is regulated by phosphorylation and interaction with beta-arrestins.
- Beta-arrestin 2's role in muOR regulation and morphine analgesia is not fully understood.
Purpose of the Study:
- To investigate the in vivo role of beta-arrestin 2 in muOR desensitization and morphine analgesia.
- To explore the potential of targeting beta-arrestin 2 for pain management.
Main Methods:
- Utilized genetically modified mice with a functional deletion of the beta-arrestin 2 gene.
- Administered morphine to assess analgesic effects and duration.
- Measured muOR desensitization and signaling pathways.
Main Results:
- Mice lacking beta-arrestin 2 exhibited significantly enhanced and prolonged morphine-induced analgesia.
- This suggests impaired muOR desensitization in the absence of beta-arrestin 2.
- Provides in vivo evidence for beta-arrestin 2's critical role in muOR regulation.
Conclusions:
- Beta-arrestin 2 is a key regulator of mu opioid receptor function in vivo.
- Inhibiting beta-arrestin 2 may potentiate morphine's analgesic effects.
- This offers potential therapeutic strategies for pain, tolerance, and dependence.
